Today: 4 February 2026
Subscribe
Browse Category

Earnings Reports News 12 January 2026

GE Aerospace stock edges up with earnings next week as Airbus flags engine delays

GE Aerospace stock edges up with earnings next week as Airbus flags engine delays

New York, Jan 12, 2026, 15:27 EST — Regular session Shares of GE Aerospace climbed 0.7% to $323.98 in Monday afternoon trading, gaining roughly $2.39 for the day. Investors are gearing up for next week’s quarterly earnings while keeping an eye on new tensions in the jet-engine supply chain, sparked by Airbus’s recent critique of deliveries from rival Pratt &…
12 January 2026
·····
Lowe’s stock edges higher while Home Depot slips; traders eye Feb. 25 earnings call

Lowe’s stock edges higher while Home Depot slips; traders eye Feb. 25 earnings call

NEW YORK, Jan 12, 2026, 15:44 EST — Regular session Lowe’s Companies, Inc. shares climbed 1.1% to $270.09 in afternoon trading Monday. Meanwhile, rival Home Depot slipped 0.6%. Lowe’s stock fluctuated between $263.83 and $270.98, with roughly 1.9 million shares traded. Wall Street steadied following an initial dip sparked by fresh concerns over the Federal Reserve’s independence. The Dow slipped…
12 January 2026
······
Urban Outfitters stock slides despite “record” holiday sales — what spooked URBN shares

Urban Outfitters stock slides despite “record” holiday sales — what spooked URBN shares

New York, Jan 12, 2026, 16:09 EST — After-hours Urban Outfitters (URBN.O) shares dropped roughly 12% Monday following a 9% increase in holiday sales—proof that even solid results can disappoint when expectations are steep. The stock hit an intraday low of $70.27 before recovering slightly to $71.49. The holiday update matters because it offers investors an early glimpse at demand…
12 January 2026
····
HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test

HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test

New York, Jan 12, 2026, 15:31 EST — Regular session Shares of HealthEquity dropped roughly 10% in Monday afternoon trading following the benefits administrator’s cautious initial fiscal 2027 outlook. The stock last traded down $9.53 at $84.62, hitting a session low around $84.51. This move is significant since HealthEquity’s longer-term targets often set the valuation benchmark for HSA custodians, whose…
12 January 2026
····
Texas Instruments stock slips as chip ETF firms; investors eye Jan. 27 earnings amid Fed jitters

Texas Instruments stock slips as chip ETF firms; investors eye Jan. 27 earnings amid Fed jitters

New York, Jan 12, 2026, 15:11 EST — Regular session. Texas Instruments shares slipped slightly on Monday afternoon, lagging behind the steadier semiconductor sector. The stock dipped roughly 0.2% to $189.85. The split matters since Texas Instruments serves as a bellwether for analog chips — those crucial components inside factory equipment, cars, and common electronics. With its next update looming,…
12 January 2026
·····
Lululemon stock rises after holiday-quarter outlook shifts to high end as LULU investors eye ICR

Lululemon stock rises after holiday-quarter outlook shifts to high end as LULU investors eye ICR

NEW YORK, Jan 12, 2026, 15:12 EST — Regular session Shares of lululemon athletica inc climbed roughly 3.2% to $210.43 Monday afternoon. The boost came after the company forecasted its fourth-quarter revenue and profit to hit the upper end of its previous guidance, driven by strong holiday demand. (Reuters) This update is crucial since the stock has acted as a…
12 January 2026
·····
Honeywell stock flat as new Google Cloud retail tech lands, Citi trims target ahead of earnings

Honeywell stock flat as new Google Cloud retail tech lands, Citi trims target ahead of earnings

New York, Jan 12, 2026, 15:00 EST — Regular session Shares of Honeywell International Inc (HON.O) ticked up roughly 0.1% to $207.5 in Monday afternoon trading, as investors digested the company’s latest product launches targeting retailers and warehouse operators. The timing is crucial as Honeywell prepares to release its fourth-quarter results and 2026 outlook on Jan. 29. Investors will be…
12 January 2026
·····
Lemonade stock hits fresh 52-week high as LMND rallies; traders watch short interest and earnings

Lemonade stock hits fresh 52-week high as LMND rallies; traders watch short interest and earnings

New York, January 12, 2026, 14:55 (ET) — Regular session Lemonade Inc shares surged 7.7% to $85.81 on Monday, pushing higher amid a wave of buying in volatile growth stocks. Earlier in the day, the online insurer’s stock hit $85.99. Lemonade surged to a new 52-week high, snapping its streak of erratic rallies and drawing renewed attention from traders. This…
12 January 2026
·····
Verizon stock slips in regular trade as ex-dividend date hits, earnings loom

Verizon stock slips in regular trade as ex-dividend date hits, earnings loom

New York, Jan 12, 2026, 14:22 EST — Regular session Verizon Communications Inc shares slipped 1.6% to $39.81 by Monday afternoon, following a Friday close of $40.46. During the session, the stock fluctuated between $39.52 and $40.08, with roughly 18.7 million shares traded. The drop follows Verizon’s ex-dividend date, when shares begin trading without the upcoming dividend entitlement. According to…
12 January 2026
····
Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

New York, Jan 12, 2026, 14:44 ET — Regular session underway Nuvation Bio Inc shares tumbled almost 18% on Monday following news of a licensing deal with Japan’s Eisai and initial sales data for its lung-cancer treatment. The stock slipped 17.7% to $6.62, after fluctuating between $8.34 and $6.32 on roughly 11.4 million shares traded. (SEC) This is crucial now…
12 January 2026
·····
Apellis (APLS) stock slides 15% after $689 mln 2025 revenue preview at JPM conference

Apellis (APLS) stock slides 15% after $689 mln 2025 revenue preview at JPM conference

New York, Jan 12, 2026, 14:41 EST — Regular session Apellis Pharmaceuticals shares dropped almost 15% Monday following the release of preliminary 2025 U.S. sales numbers ahead of its J.P. Morgan Healthcare Conference update. The move put the stock in focus as biotech firms roll out early guidance for the year. Timing is key. The J.P. Morgan meeting tends to…
12 January 2026
·····
Why Johnson & Johnson stock is up today: new Rybrevant data and earnings ahead

Why Johnson & Johnson stock is up today: new Rybrevant data and earnings ahead

New York, Jan 12, 2026, 2:38 PM EST — Regular session Shares of Johnson & Johnson climbed roughly 2.3% to $209.03 on Monday, pushing the stock near the high end of its trading range after new oncology data came out over the weekend. This move is crucial as major drugmakers face mounting pressure to demonstrate lasting growth ahead of earnings…
12 January 2026
·····
1 … 136 137 138 139 140 … 315

Stock Market Today

  • Becton Dickinson (BDX) Valuation Review Amid Mixed Share Price Performance
    February 4, 2026, 7:55 AM EST. Becton Dickinson's (BDX) share price shows short-term gains with a 2.27% rise in one day and 17.07% over 90 days, yet its long-term returns remain negative over one, three, and five years. The stock closed near $206.50, close to a fair value estimate of $204.83, implying a slight overvaluation of 0.8%. The company's upcoming separation of its Biosciences and Diagnostic Solutions segment aims to focus BDX as a pure-play medical technology firm, expected to boost cash flow and margins. However, risks such as trade tensions and execution challenges persist. Notably, a discounted cash flow (DCF) model values BDX significantly higher at approximately $330.31, suggesting a potentially undervalued opportunity depending on growth and risk assessments.
Go toTop